food and beverage distributorUpdated 29 Jul 2026

Laboratorios Finadiet

Distributor

Declared capabilities
4
Regions served
1
Is this your company?Claim Laboratorios Finadiet to get found by buyers, add products and certifications, and earn the Verified badge once you’ve reviewed your details — staying eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Laboratorios Finadiet — no cold outreach.

Overview

What Laboratorios Finadiet covers.

Laboratorios Finadiet is an Argentine pharmaceutical laboratory specializing in rare and orphan diseases. The company is dedicated to improving the quality of life of patients with these conditions through the development, manufacture, and commercialization of pharmaceutical products. Finadiet works in partnership with international companies to bring innovative treatments to Argentina, including a commercialization agreement signed with Roche for Pulmozyme (Dornase alfa) in November 2024.

  • Declared capabilities: rare diseases, orphan diseases, pharmaceutical products and specialty pharma.
  • Serves regions including Argentina.
  • Distribution channels: pharmacy.
  • Headquartered in Argentina.

Capabilities

  • rare diseases
  • orphan diseases
  • pharmaceutical products
  • specialty pharma

FAQ

Questions this page answers.

What does Laboratorios Finadiet do?

Laboratorios Finadiet is a food and beverage distributor based in Argentina with declared capabilities in rare diseases, orphan diseases and pharmaceutical products, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, and correct outdated details. Once you've claimed the page and reviewed its details, it carries the Verified badge — and stays eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Proprietary metrics remain in authenticated Talio.